PWPopi Hadi Wisnuwardhani

Popi Hadi Wisnuwardhani

*This is an algorithmically generated author record based on publicly available information.

Popi Hadi Wisnuwardhani has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluation of Carbon-Dots (CDs) as Antiviral Candidates Against SARS-CoV-2 Using a Chemical Crosslinking Method

    by Nahdiya Laila Mufida, Arum Sinda Santika, Marissa Angelina, Dian Fitria Agustiyanti, Popi Hadi Wisnuwardhani, Yana Rubiyana, Ratih Asmana Ningrum, Andri Wardiana, Hariyatun Hariyatun, Ferry Iskandar, et al.

    The chemical crosslinking method has been effective in previous studies for interaction-based drug screening. Although CDs have been widely explored as antiviral candidates, studies that use chemical crosslinking to select effective CDs against SARS-CoV-2 remain limited. To address this gap, this study uses chemical crosslinking to test CDs as antiviral compounds. The objective of this study is to screen and determine the potential of CDs as candidate antiviral compounds for inhibiting the dimerization of the SARS-CoV-2 N-CTD protein using a chemical crosslinking method. Recombinant SARS-CoV-2 N-CTD protein was expressed, purified, and precipitated for compound testing with chemical crosslinking. The concentration ranges used in the dimerization inhibition testing were 0-2,000 ppm (pyrrolic-N CDs) and 0-6,000 ppm (pyridinic-N, graphitic-N, and nuciferine-derived CDs). The study’s results show that CDs have the potential to inhibit dimerization of the SARS-CoV-2 N-CTD protein. Among the four compounds tested, pyrrolic-N CDs showed the best inhibitory potential, as they inhibited dimerization at the lowest concentration (2,000 ppm), had the smallest percentage of dimer bands to total protein, and achieved the highest dimerization inhibition efficiency. However, further research, including in vitro and in vivo tests, is needed to comprehensively evaluate the potential of pyrrolic-N CDs.

  • Open Access

    Phycocyanin from Spirulina sp. and Galdieria sp.: A systematic review of bibliometric trends, bioactivities, and structural biology

    by Fendy Fendy, Obie Farobie, Delicia Yunita Rahman, Nur Faiizah Aqiilah Firman, Khairul Anam, Naswandi Nur, Popi Hadi Wisnuwardhani, Eri Sahabudin, Syaefudin Suminto

    Phycocyanin is a blue pigment-protein complex widely produced by cyanobacteria and red algae, including Spirulina and Galdieria sp. The complex has attracted considerable attention due to its potential as a natural colorant and bioactive compound with antioxidant, anti-inflammatory, and anti-cancer properties. This review presents a comprehensive analysis of research trends, structural characteristics, and biofunctional applications of phycocyanin based on a bibliometric study using Scopus data (1973–2025) and VOSviewer. We highlight the differences in the molecular composition and thermal stability between phycocyanin derived from Spirulina and Galdieria, with Galdieria demonstrating higher heat tolerance and industrial relevance. Various extraction and purification techniques, including ultrasonication, enzymatic hydrolysis, and chromatography, were compared to assess yield and purity. Despite extensive studies on Spirulina, significant knowledge gaps remain regarding the structural biology, production scalability, and application feasibility of phycocyanin from extremophilic algae. This review identifies underexplored study areas and suggests that future studies should focus on improving extraction efficiency, assessing industrial-scale production stability, and expanding its applications in the food, cosmetic, and pharmaceutical sectors. Advancing interdisciplinary research is crucial for unlocking the full potential of phycocyanin as a sustainable and functional biopigment.

  • Open Access

    Valorization of Mixotrophic Galdieria sulphuraria Biomass for the Production of Phycocyanin: Isolation, Kinetic Stability, and Antioxidant Activity

    by Fendy Fendy, Delicia Yunita Rahman, Syaefudin Suminto, Obie Farobie, Nur Faiizah Aqiilah Firman, Popi Hadi Wisnuwardhani, Nuruliawaty Utami

    Phycocyanin is a high-value blue phycobiliprotein with immense potential in the food and pharmaceutical industries. However, its commercial application is often restricted by its thermal instability. This study investigated the production, purification, and stability of phycocyanin from the thermoacidophilic microalga Galdieria sulphuraria cultivated under mixotrophic conditions. Phycocyanin was extracted using a bead-beating method and subsequently purified using sequential ammonium sulfate precipitation (25–70% saturation) followed by dialysis. The optimized purification approach produced high spectrophotometric purity ratio phycocyanin of 8.24±2.24, a recovery of 5.74%, and a yield of 0.94±0.13 mg/g dry weight (DW). Molecular profiling by SDS-PAGE confirmed the characteristic α- and β-subunits (~16 and 19 kDa), whereas native-PAGE revealed a distinct banding pattern indicative of a stable native oligomeric complex. Kinetic stability evaluations on the isolated phycocyanin revealed remarkable thermotolerance, retaining its structural and color integrity at temperatures up to 60 °C, alongside an optimal pH stability within the mildly acidic range of 4.0–6.0 (peaking at pH 5.0). Although the pigment showed susceptibility to photolytic degradation under high-intensity illumination, it demonstrated potent in vitro antioxidant capacity, effectively scavenging both DPPH (IC50 = 44.82±0.18 μg/mL) and ABTS (IC50 = 52.20±1.01 μg/mL) free radicals. These findings suggest that mixotrophic G. sulphuraria is a promising source of highly stable phycocyanin suitable for thermal processing applications.

  • Open Access

    Evaluation of Curcumin-derived Carbon-dots' Inhibitory Activity as SARS-CoV-2 Antiviral Candidate Using Chemical Crosslinking

    by Audrey Angelina Putri Taharuddin, Nicholas Yamahoki, Rebecca Stephanie, Dian Fitria Agustiyanti, Popi Hadi Wisnuwardhani, Marissa Angelina, Yana Rubiyana, Ratih Asmana Ningrum, Andri Wardiana, Desriani Desriani, et al.

    In our previous work, we demonstrated that curcumin-derived carbon dots (Cur-CDs) have potential as antivirals for COVID-19. However, the precise mechanism of action remains unclear. This study investigated the potential of Cur-CDs against SARS-CoV-2 by targeting the dimerization of the C-terminal domain of nucleocapsid protein (N-CTD) using chemical crosslinking. Recombinant SARS-CoV-2 N-CTD was expressed, purified, and subjected to chemical crosslinking. The dimerization inhibition ability of Cur-CDs was assessed with ligand concentrations ranging from 0 to 2,000 μg/mL. Successful inhibition —defined as a noticeable reduction in SARS-CoV-2 N-CTD dimer band intensity on SDS-PAGE—was observed when Cur-CDs were present at 8 to 16 times the protein concentration. We hypothesize that Cur-CDs bind to the dimerization residues, preventing non-covalent interactions between monomers and limiting dimer formation. Our findings suggest that Cur-CDs could be a promising antiviral strategy for SARS-CoV-2, especially targeting the dimerization of the nucleocapsid protein. Additionally, this study also highlights the use of chemical crosslinking as a valuable tool for interaction-based drug screening.

  • Open Access

    SARS-CoV-2 lineages and naso-oropharyngeal bacterial communities in COVID-19 reinfection: A study in West Java, Indonesia

    by Alvira R. Sativa, Isnaini Z. Asyifa, Muhammad M. Adzdzakiy, Syam B. Iryanto, Herjuno A. Nugroho, Ari S. Wulandari, Nova D. Yanthi, Mukh F. Nasrulloh, Ema Rahmawati, Cut Nc. Alamanda, et al.

    Continuous emergence of new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants may influence viral transmission dynamics and alter interactions with the respiratory microbiota, potentially increasing the risks of reinfection. This study investigated cases of coronavirus disease 2019 (COVID-19) reinfection in West Java, Indonesia, with the aim of identifying the SARS-CoV-2 variants involved, characterizing their genomic mutations, and profiling the nasal and oropharyngeal microbiota associated with reinfection. Naso-oropharyngeal swab samples were collected from 42 COVID-19 reinfection cases and nine new infection cases. Whole genome sequencing was performed using Oxford Nanopore Technologies (ONT) MinION Mk1C and variant analysis was conducted using ARTIC workflow. Nexstrain and PANGOLIN were used to determine the lineages. Phylogenetic trees were constructed using IQ-tree and FigTree. Key mutations were identified by Cov-GLUE. Additionally, 16s rRNA amplicon sequencing was conducted on nine samples from each group to analyze bacterial communities using EPI2ME and MicrobiomeAnalyst. All identified SARS-CoV-2 strains in this study were Delta variant (B.1.617.2), predominantly lineage AY.23 (n=46, 90%), followed by AY.24 (n=3) and AY.109 (n=2). No differences in SARS-CoV-2 lineages were observed between reinfection and new infection cases. Unique hotspot mutations found only in COVID-19 reinfections included NSP3, V220A, S_T676I, ORF7a_V82A, and ORF7a_TI20I. Bacterial community analysis revealed no significant diversity differences (alpha and beta) between the two groups. While the most dominant phylum remained Terrabacteria in both groups, Streptococcus was dominant in COVID-19 reinfections, whereas Prevotella was dominant in new infection cases. Notably, Haemophilus parainfluenzae, Fusobacterium periodonticum, Fusobacterium nucleatum, and Leptotrichia buccalis had significant increases in reinfection cases. Despite the similarity in SARS-CoV-2 lineages causing both COVID-19 reinfection and new infection cases, the presence of distinct key mutations and bacterial species suggest their potential as biomarkers within this group.

  • Open Access

    Development of an inactivated viral transport medium for diagnostic testing in low-resource countries

    by Silmi Rahmani, Karlia Meitha, Popi Septiani, Neil Priharto, Kamarisima Kamarisima, Ratih A. Ningrum, Marissa Angelina, Dian F. Agustiyanti, Popi H. Wisnuwardhani, Herjuno A. Nugroho, et al.

    Viral transport medium (VTM) is crucial for retaining clinical specimens, such as the virus or its genetic material from the mucus of respiratory tract of coronavirus disease 2019 (COVID-19) suspected patients. However, the locally produced VTM in Indonesia lacks the ability to inactivate the virus, risking the safety of diagnostic personnel. The aim of this study was to formulate inactive VTM (iVTM) incorporating chaotropic agents like guanidine salt, along with anionic detergents, chelators, buffers, and surfactants, to inactivate the virus while maintaining RNA integrity. Viral RNA stability in iVTM (pH 4 and pH 6) was evaluated for 30 days at 4°C and 25–28°C. In vitro inactivation test was performed on SARS-CoV-2 isolate (variant B1). The stability test revealed that storing the clinical specimens in iVTM at pH 6 maintained severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) detectability by qPCR for up to 30 days at cold and room temperatures. Stability assessments conducted over a 4-month period (at 25–28°C) on iVTM with a pH of 6 revealed clear appearance, consistent pH stability, no alteration in the solution color, and no indications of bacterial or fungal contamination. Results from an in vitro inactivation assay demonstrated that iVTM pH 6 eliminated SARS-CoV-2 infectivity within just five minutes of contact. These findings suggest that iVTM pH 6 offers a safer and cost-effective alternative for handling and transportation of clinical specimens.

  • Open Access

    Potential neuroprotective of trans-resveratrol a promising agent tempeh and soybean seed coats-derived against beta-amyloid neurotoxicity on primary culture of nerve cells induced by 2-methoxyethanol

    by Y. Irnidayanti, D. R. Sutiono, N. Ibrahim, P. H. Wisnuwardhani, A. Santoso

    Resveratrol, a natural polyphenol found in tempeh, has not been investigated especially in vitro as a neuroprotective agent against 2-methoxyethanol (2-ME)-induced beta-amyloid cytotoxicity. Beta amyloid peptides (Aβ) could initiate neurotoxic events and neuron-inflammatory response via microglial activation. However, it remains unknown whether the neurotoxic effect of beta-amyloid and/or associated with the potential of 2-ME to induce neurotoxic effects on primary culture of nerve cells induced by 2-ME. This study investigated potential neuroprotective of trans-resveratrol a promising agent tempeh and soybean seed coats-derived against beta-amyloid cytotoxicity on primary culture of nerve cells induced by 2-methoxyethanol. Biotium and MTT assays were used to analyze neurons, which were isolated from the cerebral cortex of fetal mice at gestation day 19 (GD-19). A standard solution of 2-methoxyethanol was dosed at 10 μL. The cultured cells were randomly divided into the following groups: (1) 2-ME group + resveratrol standard, (2) 2-ME group + resveratrol isolated from tempeh, (3) 2-ME group + resveratrol isolated from soybean seed coats, and (4) the control group, without the addition of either 2-ME or resveratrol. Exposure of the primary cortical neuron cells to beta-amyloid monoclonal antibody pre-incubated for 24 h with 10 µL of 4.2 µg/mL resveratrol and 7.5 mmol/l 2-methoxy-ethanol additions. Here, we report that the addition of 2-ME and resveratrol (standard and isolated from tempeh) of cell culture at concentrations of 1.4, 2.8 and 4.2 µg/mL showed that the majority of neurons grew well. In contrast, after exposure to 2-ME and Beta-amyloid, showed that glial activated. These findings demonstrate a role for resveratrol in neuroprotective-neurorescuing action.